A study evaluating the shortened Frontal Assessment Battery (FAB15) reports that the tool is both psychometrically and clinimetrically sound for detecting executive dysfunction across neurodegenerative disorders. The work supports a streamlined clinical approach to cognitive domain screening when full assessment batteries may be impractical. The clinical framing is notable for day-to-day neurology and geriatrics practice, where execution of longer instruments can be limited by time, patient fatigue, and workflow constraints. By validating FAB15 performance characteristics, the study provides a basis for adoption in trials and routine care settings. For research teams, this may facilitate more consistent executive dysfunction measurement and potentially improve stratification in studies evaluating disease-modifying interventions.